Saudi CDMO’s fill/finish plant to offer Big Biopharma access to local benefits
Saudi Biotech Manufacturing has selected Swedish engineering firm KeyPlants to design and build a fill/finish plant for biological APIs.
Archives for February 1, 2017
Sekisui XenoTech adds new test systems to service offerings
Sekisui XenoTech has added new dermal subcellular fraction test systems to its contract research services.
Mezzion hires Pol Pharma and Halo Pharma and accuses Dr Reddy's of fraud
Mezzion has hired Pol Pharma and Halo Pharma and accused former CMO Dr Reddy’s of hiding manufacturing problems that cost its erectile dysfunction candidate, udenafil, US approval.
Evotec's new UK ADMET purchase Cyprotex completes integration move
Cyprotex is now wholly owned by Evotec and has finished moving its operations into a facility at the BioCity BioHub in Cheshire, UK.
US FDA calls CTX Lifesciences' plant remediation plan inadequate
The US FDA has asked CTX Lifesciences PVT Ltd for more details of how it will bring its API plant in India up to code.
AEMPS slams QC systems at Euro Far Alergi plant
Spanish regulators have criticised operations at a facility operated by vaccine firm Euro Far Alergi S.L.
Chiltern expands presence in India
Chiltern has opened a new process and technology center in Bangalore, India to further support its analytics, risk-based optimization, biometrics, and pharmacovigilance capabilities.
Novo Nordisk Foundation grants $17m for pharma fermentation pilot plant
The Novo Nordisk Foundation has awarded a DKK118m ($17m) grant to fund development of a fermentation pilot plant for cell line scale up experiments at the Technical University of Denmark.
InDex and Parexel trial for Ulcerative colitis won't be in US due to high cost
InDex Pharmaceuticals Holding AB has upgraded a deal with Parexel for its Phase IIb trial in Europe for ulcerative colitis, cancelling plans for US centres due to expense.